A rare subset of pediatric solid tumors including malignant rhabdoid tumors, chordomas and epithelioid sarcoma which typically have low TMB, outlier high immune infiltration and mutations affecting the SWI/SNF complex (SMARCB1/A4), have been among rare responders to ICI33. Here, SMARCA1 is linked to chordoma.